Abstract
Exogenous insulin therapy is required for the prevention of ketosis and for survival.1,2 In contrast, the pathophysiology of type 2 diabetes is believed to be a relative insulin deficiency, with insulin resistance at the level of the adipocyte and skeletal muscle coupled with defective insulin secretion and progressive loss of β-cell function.